CD8A and rheumatoid arthritis: To this end, we performed a time course analysis using CD8+ T cells isolated from RA patients (n = 6) and healthy controls (n = 6) stimulated with different concentrations of LPS, a potent TLR4 ligand (Supplementary Fig. 3).